Singapore markets closed

Iovance Biotherapeutics, Inc. (IOVA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.79+0.88 (+5.53%)
At close: 04:00PM EST
16.89 +0.10 (+0.60%)
After hours: 08:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 4.68B
Enterprise value 4.48B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)3.32k
Price/book (mrq)8.01
Enterprise value/revenue 3.77k
Enterprise value/EBITDA -10.48

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 3141.93%
S&P500 52-week change 326.89%
52-week high 318.33
52-week low 33.21
50-day moving average 39.75
200-day moving average 37.11

Share statistics

Avg vol (3-month) 310.43M
Avg vol (10-day) 325.38M
Shares outstanding 5278.93M
Implied shares outstanding 6278.93M
Float 8230.12M
% held by insiders 10.53%
% held by institutions 184.69%
Shares short (15 Feb 2024) 442.98M
Short ratio (15 Feb 2024) 47.45
Short % of float (15 Feb 2024) 418.26%
Short % of shares outstanding (15 Feb 2024) 416.79%
Shares short (prior month 12 Jan 2024) 443.27M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-25,156.85%

Management effectiveness

Return on assets (ttm)-39.86%
Return on equity (ttm)-81.91%

Income statement

Revenue (ttm)1.19M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -449.01M
Net income avi to common (ttm)-444.04M
Diluted EPS (ttm)-1.89
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)279.87M
Total cash per share (mrq)1
Total debt (mrq)75.86M
Total debt/equity (mrq)12.98%
Current ratio (mrq)2.79
Book value per share (mrq)2.28

Cash flow statement

Operating cash flow (ttm)-361.82M
Levered free cash flow (ttm)-211.47M